Protagenic Therapeutics Statistics
Total Valuation
PTIX has a market cap or net worth of $2.78 million. The enterprise value is $1.67 million.
Important Dates
The last earnings date was Thursday, November 14, 2024, after market close.
Earnings Date | Nov 14, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
PTIX has 6.79 million shares outstanding. The number of shares has increased by 2.87% in one year.
Current Share Class | 6.79M |
Shares Outstanding | 6.79M |
Shares Change (YoY) | +2.87% |
Shares Change (QoQ) | +1.93% |
Owned by Insiders (%) | 14.25% |
Owned by Institutions (%) | 5.96% |
Float | 5.83M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.68 |
P/TBV Ratio | 3.79 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.80
Current Ratio | 1.80 |
Quick Ratio | 1.34 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -410.05 |
Financial Efficiency
Return on equity (ROE) is -231.87% and return on invested capital (ROIC) is -124.50%.
Return on Equity (ROE) | -231.87% |
Return on Assets (ROA) | -94.91% |
Return on Capital (ROIC) | -124.50% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.88M |
Employee Count | 3 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.92% in the last 52 weeks. The beta is 0.29, so PTIX's price volatility has been lower than the market average.
Beta (5Y) | 0.29 |
52-Week Price Change | -53.92% |
50-Day Moving Average | 0.56 |
200-Day Moving Average | 0.83 |
Relative Strength Index (RSI) | 35.74 |
Average Volume (20 Days) | 339,605 |
Short Selling Information
The latest short interest is 175,290, so 2.58% of the outstanding shares have been sold short.
Short Interest | 175,290 |
Short Previous Month | 49,314 |
Short % of Shares Out | 2.58% |
Short % of Float | 3.01% |
Short Ratio (days to cover) | 1.33 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -5.27M |
Pretax Income | -6.01M |
Net Income | -5.65M |
EBITDA | -5.21M |
EBIT | -5.27M |
Earnings Per Share (EPS) | -$1.27 |
Full Income Statement Balance Sheet
Cash & Cash Equivalents | 1.06M |
Total Debt | n/a |
Net Cash | 1.06M |
Net Cash Per Share | $0.16 |
Equity (Book Value) | 719,007 |
Book Value Per Share | 0.15 |
Working Capital | 633,389 |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$4.54 million and capital expenditures -$93,969, giving a free cash flow of -$4.64 million.
Operating Cash Flow | -4.54M |
Capital Expenditures | -93,969 |
Free Cash Flow | -4.64M |
FCF Per Share | -$0.68 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |